The two published sequences of the pertussis toxin operon differ in 3 bp in the Si subunit gene. In this report, we provide evidence that Bordetella pertussis strains are able to produce active pertussis toxin only when they contain one of the two possible nucleotide sequences.
Pertussis toxin (PT) is an oligomeric protein released into the culture medium by Bordetella pertussis, the human pathogen responsible for whooping cough (18, 21) . This protein, which is a major virulence factor and the main component of new acellular vaccines against whooping cough (2, 14, 16, 17, 19, 22) , contains five noncovalently linked subunits (Si, S2, S3, S4, and S5) which are assembled into the A monomer (subunit S1) and the B oligomer (containing subunits S2, S3, S4, and S5, present in a 1:1:2:1 ratio) (18, 21) . Each of the five subunits is synthesized as a precursor containing a secretory leader peptide and is secreted into the periplasm of B. pertussis, where toxin assembly takes place. The assembled holotoxin is eventually secreted into the culture medium. We have recently shown that strains of B. pertussis which produce Si subunits with altered conformation are unable to secrete the holotoxin and secrete into the medium only very low amounts of the B oligomer of pertussis toxin (13) .
The genes coding for the five PT subunits are contained in a 4.7-kb EcoRI fragment and are organized as an operon (7, 9) . The PT operon has been cloned from two different B. pertussis strains, and its nucleotide sequence has been determined independently by two groups (7, 9) . Remarkably, the two nucleotide sequences showed only a 3-bp difference in the Si subunit gene. The nucleotides G-1184, C-1185, and G-1203 of the sequence described by Nicosia et al. (9) are not present in the sequence of Locht and Keith (7) . This results in the deletion of one amino acid and seven amino acid substitutions in the 193 to 200 region of the Si protein (Fig.  1) . The difference in amino acid sequence, although minimal, has already caused some ambiguities, especially in those studies in which synthetic peptides were used to investigate B-and T-cell epitopes (11, 12) . So far, both sequences have been considered possible and no efforts have been made to elucidate this discrepancy.
During physicochemical characterization of the S1 subunit of PT, we performed a mass spectrometric study of this subunit. The tryptic digest of S1 was directly analyzed by fast atom bombardment (FAB) mass spectrometry, following the FAB mapping strategy (8) . The FAB mass spectra were recorded with a VG ZAB 2SE mass spectrometer equipped with a cesium gun operating at 25 KeV (2 ,uA). The tryptic digest was lyophilized and dissolved in 5% acetic * Corresponding author. acid. A 2-,ul sample was loaded onto a glycerol-coated probe tip.
Spectra were recorded on UV paper and manually counted; signals were assigned to the corresponding peptides along the S1 sequence by using a computer program designed for this purpose (15) . Several signals corresponding to expected tryptic peptides were recorded, so that it was possible to confirm a great deal of the entire S1 sequence (Fig. 2) (7) .
To investigate whether there are two different genes coding for the S1 subunit or whether the difference in the published sequence is due to a mistake, we performed site-directed mutagenesis (14) on the S1 subunit derived from the clone sequenced by Nicosia and Rappuoli (9) to obtain an S1 subunit having the sequence published by Locht and Keith (7). The mutagenesis was done with the 0.9-kb Kpn-Xba fragment which encodes the S1 subunit (7, 9) . The BlueScript KS plasmid (Stratagene, San Diego, Calif.) was used as a vector to prepare single-stranded DNA. Fig. 3 . Finally, the mutated Kpn-Xba fragment was substituted for the wild-type fragment in the PT operon, cloned in the vector pRTP1, and then introduced into the chromosome of B. pertussis, whose wild-type PT operon had been deleted, by the method described by Stibitz et al. (20) and already used in our laboratory to generate over 50 different PT mutants (13, 14 (Fig. 4) . By enzyme-linked immunosorbent assay (10) , BP 10001 produced approximately ten times less PT than the wild-type strain. No toxic activity could be detected in the CHO cell assay (4 
